How interval training affects ‘belly fat’ in obese 70-year-olds
By today’s estimates, one-third of adults aged 65 or older are obese. This growing obesity trend, along with the decrease in our level of physical activity as we… read more.
By today’s estimates, one-third of adults aged 65 or older are obese. This growing obesity trend, along with the decrease in our level of physical activity as we… read more.
People who follow the paleo diet have twice the amount of a key blood biomarker linked closely to heart disease, the world’s first major study examining the impact… read more.
A new study has found that halving the amount red and processed (RPM) meat in the diet can have a significant impact on health, reducing the amount of… read more.
People with high blood pressure who take all their anti-hypertensive medication in one go at bedtime have better controlled blood pressure and a significantly lower risk of death… read more.
After 170 years, nobody was quite sure where anesthesia worked on the brain
BOSTON – Patients significantly overestimate the anticipated amount of pain they’ll experience following surgery, which researchers say can cause unnecessary anxiety in patients, according to a study being… read more.
These kidney macrophages reprogram to a developmental state after kidney injury, similar to those in newborn mice.
Most patients die within 5 years and spend two-thirds of remaining life as an inpatient.
Deep Brain Stimulation Surgery Deep Brain Stimulation (DBS), lesion surgery, and other new and innovative technologies are currently being used at UF to treat the symptoms of Parkinson’s… read more.
Serrated polyposis is one of the most common polyp syndromes in clinical practice and is often unrecognized during colonoscopy.
In a press release on August 8, 2012, Amgen announced that the company was halting a late-stage trial of its monoclonal antibody IGF-1 receptor antagonist ganitumab (AMG-479).
In news that is bound to excite breast cancer patients and investors, Genentech/Roche/Immunogen issued press releases on August 26, 2012, confirming that their drug-of-the-moment T-DM1 (trastuzumab emtansine) offers… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.